ReCyte Therapeutics to Develop Therapies for Age-Related Cardiovascular and Blood Disorders, BioTime (AMEX: BTX)
January 3rd, 2011
No comments
BTX announced a $4M equity financing of subsidiary, which will be renamed ReCyte Therapeutics Read more…
Categories: AMEX: BTX, New Cell Banking Services, Stem Cell Technology
